Li Ka Shing Applied Virology Institute (AVI)
The Li Ka Shing Applied Virology Institute (LKSAVI or AVI) is the translation and commercialization hub of the Li Ka Shing Institute of Virology.
AVI Featured News
LKSIoV Seminar with Dr. Warren Wakarchuk
Join us on Thursday, April 27 for this fascinating presentation.
The Canadian Critical Drug Initiative, led by Applied Pharmaceutical Innovation and the Li Ka Shing Applied Virology Institute, receives $80.5M from federal government
Canadian Critical Drug Initiative will commercialize new drug discoveries and prevent future shortages by producing homegrown supply.
Biden Administration, Others Working Towards Eliminating Hepatitis C
In its latest budget, the Biden administration has earmarked over $11 billion dollars for HCV care funding over the next 5 years.
About AVI
Our mission is to help transition nascent technologies in the life sciences sector into clinical relevance, providing funding, technology development support and commercialization guidance.
Current Projects
We manage and explore various commercialization projects aimed at improving human health. Our active broad portfolio of programs include vaccines, therapeutics, diagnostics, and the development of research tools for each project.
Research Articles
Our researchers actively publish their findings in reputable, peer-reviewed journals.
Support and Give to AVI
We count on you to make a difference. We require your support to ensure the continuance of the scientific advancements currently being made at the LKSAVI.